Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (1-10 of 284) with videos related to

Pageof 29
Sort By:
Nature Reviews. Microbiology|March 27, 2004
Virus entry: molecular mechanisms and biomedical applicationsDimiter S Dimitrov
Mabs|April 20, 2010
Therapeutic antibodies, vaccines and antibodyomesDimiter S Dimitrov
Mabs|January 5, 2010
Engineered CH2 domains (nanoantibodies)Dimiter S Dimitrov
Cell Chemical Biology|September 21, 2019
From Catalytic Antibodies to Antibody-Drug ConjugatesDimiter S Dimitrov
Cell|December 17, 2003
The secret life of ACE2 as a receptor for the SARS virusDimiter S Dimitrov
Methods in Molecular Biology (Clifton, N.J.)|June 28, 2012
Therapeutic proteinsDimiter S Dimitrov
Cell|April 24, 2007
Targeting the sticky fingers of HIV-1Robert Blumenthal, Dimiter S Dimitrov
Oncoimmunology|December 18, 2012
Antibody-based therapeutics against components of the IGF systemYang Feng, Dimiter S Dimitrov
Current Opinion in Drug Discovery & Development|February 20, 2008
Monoclonal antibodies against components of the IGF system for cancer treatmentYang Feng, Dimiter S Dimitrov
AIDS Research and Human Retroviruses|August 11, 2011
Monoclonal antibody-based candidate therapeutics against HIV type 1Weizao Chen, Dimiter S Dimitrov
Pageof 29

Showing results (1-10 of 284) with videos related to

Sort By:
Pageof 29
Nature Reviews. Microbiology|March 27, 2004
Virus entry: molecular mechanisms and biomedical applicationsDimiter S Dimitrov
Mabs|April 20, 2010
Therapeutic antibodies, vaccines and antibodyomesDimiter S Dimitrov
Mabs|January 5, 2010
Engineered CH2 domains (nanoantibodies)Dimiter S Dimitrov
Cell Chemical Biology|September 21, 2019
From Catalytic Antibodies to Antibody-Drug ConjugatesDimiter S Dimitrov
Cell|December 17, 2003
The secret life of ACE2 as a receptor for the SARS virusDimiter S Dimitrov
Methods in Molecular Biology (Clifton, N.J.)|June 28, 2012
Therapeutic proteinsDimiter S Dimitrov
Cell|April 24, 2007
Targeting the sticky fingers of HIV-1Robert Blumenthal, Dimiter S Dimitrov
Oncoimmunology|December 18, 2012
Antibody-based therapeutics against components of the IGF systemYang Feng, Dimiter S Dimitrov
Current Opinion in Drug Discovery & Development|February 20, 2008
Monoclonal antibodies against components of the IGF system for cancer treatmentYang Feng, Dimiter S Dimitrov
AIDS Research and Human Retroviruses|August 11, 2011
Monoclonal antibody-based candidate therapeutics against HIV type 1Weizao Chen, Dimiter S Dimitrov
Pageof 29